Payment overview · 2025
General Payments
$202.21
2 reported records · 2 companies
Healthcare provider profile · identity verified
Kelli Sloey
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner · FORT MYERS, FL · NPI 1114370343
Verified facts
What the public records show
CMS Open Payments records show Kelli Sloey received $202.21 in general payments during 2025 across 2 reported records.
Teva Pharmaceuticals USA, Inc. accounted for 60.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Teva Pharmaceuticals USA, Inc. | Unresolved — no canonical attribution shown | $121.84 | 60.2% | 1 | 2025 |
| GENZYME CORPORATION | Unresolved — no canonical attribution shown | $80.37 | 39.8% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $202.21 | 2 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| AUSTEDO XR Normalized: austedo xr |
Drug | Teva Pharmaceuticals USA, Inc. | $121.84 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Pantoprazole Sodium | Pantoprazole Sodium | 325 | 36 |
| Atorvastatin Calcium | Atorvastatin Calcium | 288 | 29 |
| Amlodipine Besylate | Amlodipine Besylate | 245 | 30 |
| Gabapentin | Gabapentin | 229 | 21 |
| Furosemide | Furosemide | 221 | 24 |
| Metoprolol Succinate | Metoprolol Succinate | 211 | 23 |
| Levothyroxine Sodium | Levothyroxine Sodium | 195 | 23 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 178 | 21 |
| Trazodone Hcl | Trazodone Hcl | 176 | 18 |
| Famotidine | Famotidine | 174 | 18 |
| Losartan Potassium | Losartan Potassium | 158 | 19 |
| Tamsulosin Hcl | Tamsulosin Hcl | 154 | 17 |
| Clonazepam | Clonazepam | 150 | 12 |
| Quetiapine Fumarate | Quetiapine Fumarate | 147 | 14 |
| Memantine Hcl | Memantine Hcl | 135 | 18 |
| Eliquis | Apixaban | 129 | 15 |
| Sertraline Hcl | Sertraline Hcl | 114 | 13 |
| Potassium Chloride | Potassium Chloride | 104 | 15 |
| Omeprazole | Omeprazole | 100 | 12 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 93 | 11 |
| Buspirone Hcl | Buspirone Hcl | 90 | 14 |
| Divalproex Sodium | Divalproex Sodium | 83 | 12 |
| Lisinopril | Lisinopril | 83 | 11 |
| Carvedilol | Carvedilol | 82 | suppressed |
| Bumetanide | Bumetanide | 81 | suppressed |
| Spironolactone | Spironolactone | 80 | suppressed |
| Clopidogrel | Clopidogrel Bisulfate | 78 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 78 | 17 |
| Alendronate Sodium | Alendronate Sodium | 75 | suppressed |
| Donepezil Hcl | Donepezil Hcl | 75 | 15 |
| Escitalopram Oxalate | Escitalopram Oxalate | 69 | 13 |
| Metoprolol Tartrate | Metoprolol Tartrate | 66 | suppressed |
| Mirabegron Er | Mirabegron | 66 | suppressed |
| Prednisone | Prednisone | 66 | 12 |
| Levetiracetam | Levetiracetam | 64 | suppressed |
| Simvastatin | Simvastatin | 64 | suppressed |
| Calcitriol | Calcitriol | 62 | suppressed |
| Ammonium Lactate | Ammonium Lactate | 59 | 27 |
| Xarelto | Rivaroxaban | 59 | suppressed |
| Montelukast Sodium | Montelukast Sodium | 58 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 56 | suppressed |
| Hydralazine Hcl | Hydralazine Hcl | 56 | suppressed |
| Metformin Hcl | Metformin Hcl | 56 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 54 | 30 |
| Finasteride | Finasteride | 53 | suppressed |
| Jardiance | Empagliflozin | 53 | suppressed |
| Duloxetine Hcl | Duloxetine Hcl | 52 | suppressed |
| Gemtesa | Vibegron | 52 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 48 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 48 | suppressed |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 47 | suppressed |
| Myrbetriq | Mirabegron | 46 | suppressed |
| Meloxicam | Meloxicam | 45 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 42 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 41 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 39 | suppressed |
| Benztropine Mesylate | Benztropine Mesylate | 39 | suppressed |
| Glipizide | Glipizide | 38 | suppressed |
| Methylprednisolone | Methylprednisolone | 38 | 29 |
| Aripiprazole | Aripiprazole | 37 | suppressed |
| Fluticasone Propionate | Fluticasone Propionate | 37 | 14 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 37 | suppressed |
| Cefuroxime | Cefuroxime Axetil | 36 | 28 |
| Toujeo Max Solostar | Insulin Glargine,hum.Rec.Anlog | 36 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 35 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 35 | suppressed |
| Atenolol | Atenolol | 33 | suppressed |
| Doxycycline Hyclate | Doxycycline Hyclate | 33 | 21 |
| Methenamine Hippurate | Methenamine Hippurate | 33 | suppressed |
| Risperidone | Risperidone | 32 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 31 | 15 |
| Rivastigmine | Rivastigmine | 31 | suppressed |
| Loperamide | Loperamide Hcl | 30 | suppressed |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 29 | suppressed |
| Latanoprost | Latanoprost | 29 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 29 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 29 | suppressed |
| Celecoxib | Celecoxib | 28 | suppressed |
| Ezetimibe | Ezetimibe | 28 | suppressed |
| Glimepiride | Glimepiride | 28 | suppressed |
| Telmisartan | Telmisartan | 28 | suppressed |
| Allopurinol | Allopurinol | 27 | suppressed |
| Temazepam | Temazepam | 27 | suppressed |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 26 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 26 | suppressed |
| Entresto | Sacubitril/Valsartan | 26 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 26 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 25 | suppressed |
| Ozempic | Semaglutide | 25 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 25 | suppressed |
| Alprazolam | Alprazolam | 24 | suppressed |
| Armour Thyroid | Thyroid,pork | 24 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 24 | suppressed |
| Olanzapine | Olanzapine | 23 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 23 | suppressed |
| Azithromycin | Azithromycin | 22 | 18 |
| Brimonidine Tartrate | Brimonidine Tartrate | 22 | suppressed |
| Febuxostat | Febuxostat | 22 | suppressed |
| Ondansetron Odt | Ondansetron | 22 | suppressed |
| Valsartan | Valsartan | 22 | suppressed |
| Buprenorphine | Buprenorphine | 21 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 21 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 21 | suppressed |
| Novofine 32 | Pen Needle, Diabetic | 21 | suppressed |
| Clonidine | Clonidine | 20 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 19 | suppressed |
| Levofloxacin | Levofloxacin | 19 | 12 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 19 | 13 |
| Buprenorphine-Naloxone | Buprenorphine Hcl/Naloxone Hcl | 18 | suppressed |
| Ketoconazole | Ketoconazole | 18 | suppressed |
| Mupirocin | Mupirocin | 18 | 13 |
| Propranolol Hcl | Propranolol Hcl | 17 | suppressed |
| Colestipol Hcl | Colestipol Hcl | 16 | suppressed |
| Mirtazapine | Mirtazapine | 15 | suppressed |
| Phenazopyridine Hcl | Phenazopyridine Hcl | 15 | suppressed |
| Brilinta | Ticagrelor | 14 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 14 | suppressed |
| Leflunomide | Leflunomide | 14 | suppressed |
| Methazolamide | Methazolamide | 14 | suppressed |
| Multaq | Dronedarone Hcl | 14 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 14 | suppressed |
| Risedronate Sodium Dr | Risedronate Sodium | 14 | suppressed |
| Trimethoprim | Trimethoprim | 14 | suppressed |
| Ultra-Fine Mini Pen Needle | Pen Needle, Diabetic | 14 | suppressed |
| Zolpidem Tartrate | Zolpidem Tartrate | 14 | suppressed |
| Diltiazem 24hr Er | Diltiazem Hcl | 13 | suppressed |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 13 | suppressed |
| Dutasteride | Dutasteride | 13 | suppressed |
| Flecainide Acetate | Flecainide Acetate | 13 | suppressed |
| Haloperidol Decanoate | Haloperidol Decanoate | 13 | suppressed |
| Ipratropium Bromide | Ipratropium Bromide | 13 | suppressed |
| Nifedipine Er | Nifedipine | 13 | suppressed |
| Ondansetron Hcl | Ondansetron Hcl | 13 | suppressed |
| Premarin | Estrogens, Conjugated | 13 | suppressed |
| Pyridostigmine Bromide | Pyridostigmine Bromide | 13 | suppressed |
| Triazolam | Triazolam | 13 | suppressed |
| Zolpidem Tartrate Er | Zolpidem Tartrate | 13 | suppressed |
| Binosto | Alendronate Sodium | 12 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 12 | suppressed |
| Lorazepam | Lorazepam | 12 | suppressed |
| Permethrin | Permethrin | 12 | suppressed |
| Prednisolone Acetate | Prednisolone Acetate | 12 | suppressed |
| Pregabalin | Pregabalin | 12 | suppressed |
| Tobramycin | Tobramycin | 12 | suppressed |
| Estradiol | Estradiol | 11 | suppressed |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 11 | suppressed |
| Ivermectin | Ivermectin | 11 | suppressed |
| Oxybutynin Chloride | Oxybutynin Chloride | 11 | suppressed |
| Tizanidine Hcl | Tizanidine Hcl | 11 | suppressed |
| Ultra-Fine Short Pen Needle | Pen Needle, Diabetic | 11 | suppressed |
| Zenpep | Lipase/Protease/Amylase | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $202.21 · 2 records | Teva Pharmaceuticals USA, Inc. | AUSTEDO XR | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error